Biohaven Pharmaceutical Holding Co Ltd.

Capital International Investors

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/14/2022

Shares

1,525,202

Value ($000)

231

Weight

0.1%

2019 Q4 - 2022 Q3 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/14/2022	231	0.1%	1,525,202	9/30/2022
2022 Q2	8/15/2022	222	0.1%	1,525,365	6/30/2022
2022 Q1	5/19/2022	318	0.1%	2,682,916	3/31/2022
2021 Q4	2/14/2022	690	0.1%	5,005,826	12/31/2021
2021 Q3	11/15/2021	745	0.2%	5,365,065	9/30/2021
2021 Q2	8/16/2021	548	0.1%	5,641,062	6/30/2021
2021 Q1	5/14/2021	381	0.1%	5,578,232	3/31/2021
2020 Q4	2/12/2021	457	0.1%	5,330,978	12/31/2020
2020 Q3	11/13/2020	374	0.1%	5,747,185	9/30/2020
2020 Q2	8/14/2020	439	0.1%	6,010,015	6/30/2020
2020 Q1	5/15/2020	204	0.1%	6,003,735	3/31/2020
2019 Q4	2/18/2020	159	0.1%	2,921,704	12/31/2019